Chitosan-based nanomaterial as immune adjuvant and delivery carrier for vaccines

X Gong, Y Gao, J Shu, C Zhang, K Zhao - Vaccines, 2022 - mdpi.com
With the support of modern biotechnology, vaccine technology continues to iterate. The
safety and efficacy of vaccines are some of the most important areas of development in the …

Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a …

L Mao, J Du, X Wang, L Xu, Y Zhang, Q Sun… - ACS Infectious …, 2023 - ACS Publications
The resuscitation of dormant Mycobacterium tuberculosis is an important cause of adult
tuberculosis (TB) transmission. According to the interaction mechanism between M …

[HTML][HTML] Tuberculosis Coinfection among COVID-19 Patients: Clinical Presentation and Mortality in a Tertiary Lung Hospital in Indonesia

H Muflihah, FA Yulianto, E Sampurno… - The International …, 2024 - journals.lww.com
Background: Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are the top two
killers of infectious disease. We aimed to determine the association of TB coinfection with …

[HTML][HTML] Scientometric analysis of Mycobacterium tuberculosis revaccination: Dynamics, impact and analysis of collaborative networks

LRC Vieira, ASV Dávila, F Mayta-Tovalino - Lung India, 2025 - journals.lww.com
Background: Mycobacterium tuberculosis (M. tuberculosis) is an infectious disease that
remains a significant global health problem. Despite efforts to reduce the disease, the …

[HTML][HTML] Tuberculosis control by novel vaccines development and Indian initiatives

PK Ghosh - MGM Journal of Medical Sciences, 2023 - journals.lww.com
Pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the worst
microbial diseases of humankind and an awful societal problem, especially in …